Starpharma Holdings Ltd has released a press release.
Quarterly Activities/Appendix 4C Cash Flow Report
Earlier from Starpharma
- AGM Chair address and CEO presentation
- Upfront payment of USD $5.5 million received from Genentech
- SPL: Research & Option Agreement with Radiopharm Theranostics